Cargando…
Management of neuropathic pain
Neuropathic pain is intractable pain caused by damage to the nervous system. Recent approval and expansion of the indications of a series of drugs are expected to improve the treatment strategies for neuropathic pain. Here, we present an outline of pain transmission pathways and relevant pharmacolog...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689392/ https://www.ncbi.nlm.nih.gov/pubmed/29263992 http://dx.doi.org/10.1002/jgf2.5 |
_version_ | 1783279373881704448 |
---|---|
author | Nishikawa, Noriko Nomoto, Masahiro |
author_facet | Nishikawa, Noriko Nomoto, Masahiro |
author_sort | Nishikawa, Noriko |
collection | PubMed |
description | Neuropathic pain is intractable pain caused by damage to the nervous system. Recent approval and expansion of the indications of a series of drugs are expected to improve the treatment strategies for neuropathic pain. Here, we present an outline of pain transmission pathways and relevant pharmacological effects, along with points to consider in the use of neuropathic pain medications according to the guidelines of Japan Society of Pain Clinicians. The content of this article is almost similar to my other Japanese article that was published in the Journal of the Japanese Society of Internal Medicine. Although complete recovery from pain may be difficult, pharmacotherapy can relieve pain, thereby improving the patients’ quality of life. |
format | Online Article Text |
id | pubmed-5689392 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56893922017-12-20 Management of neuropathic pain Nishikawa, Noriko Nomoto, Masahiro J Gen Fam Med Review Articles Neuropathic pain is intractable pain caused by damage to the nervous system. Recent approval and expansion of the indications of a series of drugs are expected to improve the treatment strategies for neuropathic pain. Here, we present an outline of pain transmission pathways and relevant pharmacological effects, along with points to consider in the use of neuropathic pain medications according to the guidelines of Japan Society of Pain Clinicians. The content of this article is almost similar to my other Japanese article that was published in the Journal of the Japanese Society of Internal Medicine. Although complete recovery from pain may be difficult, pharmacotherapy can relieve pain, thereby improving the patients’ quality of life. John Wiley and Sons Inc. 2017-04-12 /pmc/articles/PMC5689392/ /pubmed/29263992 http://dx.doi.org/10.1002/jgf2.5 Text en © 2017 The Authors. Journal of General and Family Medicine published by John Wiley & Sons Australia, Ltd on behalf of Japan Primary Care Association. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Review Articles Nishikawa, Noriko Nomoto, Masahiro Management of neuropathic pain |
title | Management of neuropathic pain |
title_full | Management of neuropathic pain |
title_fullStr | Management of neuropathic pain |
title_full_unstemmed | Management of neuropathic pain |
title_short | Management of neuropathic pain |
title_sort | management of neuropathic pain |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689392/ https://www.ncbi.nlm.nih.gov/pubmed/29263992 http://dx.doi.org/10.1002/jgf2.5 |
work_keys_str_mv | AT nishikawanoriko managementofneuropathicpain AT nomotomasahiro managementofneuropathicpain |